ABIVAX: Distribution of Shares and Voting Rights as of May 31, 2026

On June 17, 2026, ABIVAX, listed on Euronext Paris, released regulatory information regarding its share capital. The share capital amounts to €797,829.41, comprised of 79,782,941 shares. The total number of theoretical and exercisable voting rights is 82,130,598.

This data complies with Article L. 233-8 II of the French Commercial Code and the recommendations of the French Financial Markets Authority (AMF). Theoretical voting rights include shares without voting rights, while exercisable voting rights are exempt, in accordance with the AMF's recommendations since 2007.